Warren Hosseinion - Net Worth and Insider Trading

Warren Hosseinion Net Worth

The estimated net worth of Warren Hosseinion is at least $24 Million dollars as of 2024-11-13. Warren Hosseinion is the Co-CEO of Astrana Health Inc and owns about 524,438 shares of Astrana Health Inc (ASTH) stock worth over $23 Million. Warren Hosseinion is the Director of Clinigence Holdings Inc and owns about 237,521 shares of Clinigence Holdings Inc (CLNH) stock worth over $2 Million. Warren Hosseinion is also the President of Nutex Health Inc and owns about 1,660 shares of Nutex Health Inc (NUTX) stock worth over $62,350. Details can be seen in Warren Hosseinion's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Warren Hosseinion has not made any transactions after 2022-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Warren Hosseinion

Warren Hosseinion Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Warren Hosseinion owns 5 companies in total, including Clinigence Holdings Inc (CLNH) , Astrana Health Inc (ASTH) , and Nutex Health Inc (NUTX) among others .

Click here to see the complete history of Warren Hosseinion’s form 4 insider trades.

Insider Ownership Summary of Warren Hosseinion

Ticker	Comapny	Transaction Date	Type of Owner
CLNH	Clinigence Holdings Inc	2020-08-12	director
ASTH	Astrana Health Inc	2018-11-28	director & 10 percent owner & Chief Executive Officer
NUTX	Nutex Health Inc	2022-09-15	director
		2022-09-13	director
		2023-06-23	director

Warren Hosseinion Latest Holdings Summary

Warren Hosseinion currently owns a total of 3 stocks. Among these stocks, Warren Hosseinion owns 524,438 shares of Astrana Health Inc (ASTH) as of November 28, 2018, with a value of $23 Million and a weighting of 93.43%. Warren Hosseinion owns 237,521 shares of Clinigence Holdings Inc (CLNH) as of August 12, 2020, with a value of $2 Million and a weighting of 6.31%. Warren Hosseinion also owns 1,660 shares of Nutex Health Inc (NUTX) as of September 15, 2022, with a value of $62,350 and a weighting of 0.26%.

Latest Holdings of Warren Hosseinion

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ASTH	Astrana Health Inc	2018-11-28	524,438	42.93	22,514,123
CLNH	Clinigence Holdings Inc	2020-08-12	237,521	6.40	1,520,134
NUTX	Nutex Health Inc	2022-09-15	1,660	37.56	62,350

Holding Weightings of Warren Hosseinion

Warren Hosseinion Form 4 Trading Tracker

According to the SEC Form 4 filings, Warren Hosseinion has made a total of 0 transactions in Astrana Health Inc (ASTH) over the past 5 years. The most-recent trade in Astrana Health Inc is the sale of 35,000 shares on November 28, 2018, which brought Warren Hosseinion around $581,000.

According to the SEC Form 4 filings, Warren Hosseinion has made a total of 1 transactions in Clinigence Holdings Inc (CLNH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Clinigence Holdings Inc is the acquisition of 31,746 shares on August 12, 2020, which cost Warren Hosseinion around $635 Million.

According to the SEC Form 4 filings, Warren Hosseinion has made a total of 3 transactions in Nutex Health Inc (NUTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Nutex Health Inc is the sale of 1,333 shares on September 15, 2022, which brought Warren Hosseinion around $486,000.

Insider Trading History of Warren Hosseinion

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Warren Hosseinion Trading Performance

GuruFocus tracks the stock performance after each of Warren Hosseinion's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Warren Hosseinion is -9.09%. GuruFocus also compares Warren Hosseinion's trading performance to market benchmark return within the same time period. The performance of stocks bought by Warren Hosseinion within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Warren Hosseinion's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Warren Hosseinion

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	22.38
Relative Return to S&P 500(%)	23.54

Warren Hosseinion Ownership Network

Ownership Network List of Warren Hosseinion

No Data

Ownership Network Relation of Warren Hosseinion

Warren Hosseinion Owned Company Details

What does Clinigence Holdings Inc do?

Who are the key executives at Clinigence Holdings Inc?

Warren Hosseinion is the director of Clinigence Holdings Inc. Other key executives at Clinigence Holdings Inc include director & 10 percent owner Terence Martin Breslin , Chief Executive Officer Lawrence Schimmel , and director & Chief Financial Officer Elisa V Luqman .

Clinigence Holdings Inc (CLNH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clinigence Holdings Inc (CLNH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clinigence Holdings Inc (CLNH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clinigence Holdings Inc (CLNH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clinigence Holdings Inc Insider Transactions

No Available Data

What does Astrana Health Inc do?

Who are the key executives at Astrana Health Inc?

Warren Hosseinion is the director & 10 percent owner & Chief Executive Officer of Astrana Health Inc. Other key executives at Astrana Health Inc include See Remarks Chandan Basho , SVP-Chief Accounting Officer John Vong , and 10 percent owner Allied Physicians Of California, A Profession Medical Corp .

Astrana Health Inc (ASTH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Astrana Health Inc (ASTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Astrana Health Inc (ASTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Astrana Health Inc (ASTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Astrana Health Inc Insider Transactions

No Available Data

What does Nutex Health Inc do?

Who are the key executives at Nutex Health Inc?

Warren Hosseinion is the director of Nutex Health Inc. Other key executives at Nutex Health Inc include Chief Financial Officer Jon Christian Bates , Chief Operating Officer Joshua Detillio , and director & Chairman & CEO Thomas T. Vo .

Nutex Health Inc (NUTX) Insider Trades Summary

Over the past 18 months, Warren Hosseinion made no insider transaction in Nutex Health Inc (NUTX). Other recent insider transactions involving Nutex Health Inc (NUTX) include a net purchase of 2,572,478 shares made by Thomas T. Vo , a net purchase of 161,875 shares made by Joshua Detillio , and a net purchase of 21,350 shares made by Jon Christian Bates .

In summary, during the past 3 months, insiders sold 0 shares of Nutex Health Inc (NUTX) in total and bought 141,155 shares, with a net purchase of 141,155 shares. During the past 18 months, 0 shares of Nutex Health Inc (NUTX) were sold and 169,016 shares were bought by its insiders, resulting in a net purchase of 169,016 shares.

Nutex Health Inc (NUTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nutex Health Inc Insider Transactions

No Available Data

What does Altitude Acquisition Corp do?

Who are the key executives at Altitude Acquisition Corp?

Warren Hosseinion is the director of Altitude Acquisition Corp. Other key executives at Altitude Acquisition Corp include 10 percent owner Bnp Paribas Arbitrage, Sa , director & 10 percent owner Altitude Acquisition Holdco Llc , and 10 percent owner Gary Teplis .

Altitude Acquisition Corp (ALTUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Altitude Acquisition Corp (ALTUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Altitude Acquisition Corp (ALTUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Altitude Acquisition Corp (ALTUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altitude Acquisition Corp Insider Transactions

No Available Data

What does Cardio Diagnostics Holdings Inc do?

Who are the key executives at Cardio Diagnostics Holdings Inc?

Warren Hosseinion is the director of Cardio Diagnostics Holdings Inc. Other key executives at Cardio Diagnostics Holdings Inc include director & 10 percent owner & Chief Medical Officer Robert Philibert , Chief Technology Officer Timur Dogan , and director & 10 percent owner & Chief Executive Officer Meeshanthini Dogan .

Cardio Diagnostics Holdings Inc (CDIO) Insider Trades Summary

Over the past 18 months, Warren Hosseinion made no insider transaction in Cardio Diagnostics Holdings Inc (CDIO). Other recent insider transactions involving Cardio Diagnostics Holdings Inc (CDIO) include a net purchase of 225,146 shares made by Meeshanthini Dogan , a net purchase of 87,216 shares made by Timur Dogan , and a net purchase of 68,075 shares made by Robert Philibert .

In summary, during the past 3 months, insiders sold 0 shares of Cardio Diagnostics Holdings Inc (CDIO) in total and bought 309,935 shares, with a net purchase of 309,935 shares. During the past 18 months, 0 shares of Cardio Diagnostics Holdings Inc (CDIO) were sold and 380,437 shares were bought by its insiders, resulting in a net purchase of 380,437 shares.

Cardio Diagnostics Holdings Inc (CDIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cardio Diagnostics Holdings Inc Insider Transactions

No Available Data

Warren Hosseinion Mailing Address

Above is the net worth, insider trading, and ownership report for Warren Hosseinion. You might contact Warren Hosseinion via mailing address: C/o 1668 S. Garfield Avenue, 2nd Floor, Alhambra Ca 91801.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.